Literature DB >> 34941434

Exercise reduces the protein abundance of TXNIP and its interacting partner REDD1 in skeletal muscle: potential role for a PKA-mediated mechanism.

Alec B Chaves1, Edwin R Miranda2, Jacob T Mey3, Brian K Blackburn4, Kelly N Z Fuller5, Blaise Stearns2, Andrew Ludlow2, David L Williamson6, Joseph A Houmard1, Jacob M Haus2.   

Abstract

Thioredoxin-interacting protein (TXNIP) negatively effects the redox state and growth signaling via its interactions with thioredoxin (TRX) and regulated in development and DNA damage response 1 (REDD1), respectively. TXNIP expression is downregulated by pathways activated during aerobic exercise (AE), via posttranslational modifications (PTMs; serine phosphorylation and ubiquitination). The purpose of this investigation was to determine the effects of acute AE on TXNIP expression, posttranslational modifications, and its interacting partners, REDD1 and TRX. Fifteen healthy adults performed 30 min of aerobic exercise (80% V̇o2max) with muscle biopsies taken before, immediately following, and 3 h following the exercise bout. To explore potential mechanisms underlying our in vivo findings, primary human myotubes were exposed to two models of exercise, electrical pulse stimulation (EPS) and palmitate-forskolin-ionomycin (PFI). Immediately following exercise, TXNIP protein decreased, but returned to preexercise levels 3 h after exercise. These results were replicated in our PFI exercise model only. Although not statistically significant, there was a trending main effect in serine-phosphorylation status of TXNIP (P = 0.07) immediately following exercise. REDD1 protein decreased 3 h after exercise. AE had no effect on TRX protein expression, gene expression, or the activity of its reducing enzyme, thioredoxin reductase. Consequently, AE had no effect on the TRX: TXNIP interaction. Our results indicate that AE leads to acute reductions in TXNIP and REDD1 protein expression. However, these changes did not result in alterations in the TRX: TXNIP interaction and could not be entirely explained by alterations in TXNIP PTMs or changes in TRX expression or activity.NEW & NOTEWORTHY Aerobic exercise is an effective tool in the prevention and treatment of several chronic metabolic diseases. However, the mechanisms through which these benefits are conferred have yet to be fully elucidated. Our data reveal a novel effect of aerobic exercise on reducing the protein expression of molecular targets that negatively impact redox and insulin/growth signaling in skeletal muscle. These findings contribute to the expanding repository of molecular signatures provoked by aerobic exercise.

Entities:  

Keywords:  physical activity; proteome; redox; signaling

Mesh:

Substances:

Year:  2021        PMID: 34941434      PMCID: PMC8791844          DOI: 10.1152/japplphysiol.00229.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  41 in total

1.  Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells.

Authors:  Ichiro Kawahata; Hirofumi Tokuoka; Hasan Parvez; Hiroshi Ichinose
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 2.  Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction.

Authors:  A M Abbatecola; G Paolisso; P Fattoretti; W J Evans; V Fiore; L Dicioccio; F Lattanzio
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

3.  The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.

Authors:  Parth Patwari; Luke J Higgins; William A Chutkow; Jun Yoshioka; Richard T Lee
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

4.  TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1.

Authors:  H-O Jin; S-K Seo; Y-S Kim; S-H Woo; K-H Lee; J-Y Yi; S-J Lee; T-B Choe; J-H Lee; S An; S-I Hong; I-C Park
Journal:  Oncogene       Date:  2011-04-04       Impact factor: 9.867

5.  Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans.

Authors:  A J Wadley; Y W Chen; S J Bennett; G Y H Lip; J E Turner; J P Fisher; S Aldred
Journal:  Free Radic Res       Date:  2015-02-04

6.  Markers of human skeletal muscle mitochondrial biogenesis and quality control: effects of age and aerobic exercise training.

Authors:  Adam R Konopka; Miranda K Suer; Christopher A Wolff; Matthew P Harber
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-20       Impact factor: 6.053

7.  FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.

Authors:  Sandra Pereira; Edward Park; Yusaku Mori; C Andrew Haber; Ping Han; Toyoyoshi Uchida; Laura Stavar; Andrei I Oprescu; Khajag Koulajian; Alexander Ivovic; Zhiwen Yu; Deling Li; Thomas A Bowman; Jay Dewald; Jamel El-Benna; David N Brindley; Roger Gutierrez-Juarez; Tony K T Lam; Sonia M Najjar; Robert A McKay; Sanjay Bhanot; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-13       Impact factor: 4.310

8.  Endurance exercise induces REDD1 expression and transiently decreases mTORC1 signaling in rat skeletal muscle.

Authors:  Miki Hayasaka; Haruka Tsunekawa; Mariko Yoshinaga; Taro Murakami
Journal:  Physiol Rep       Date:  2014-12-24

Review 9.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise.

Authors:  Riki Ogasawara; Satoshi Fujita; Troy A Hornberger; Yu Kitaoka; Yuhei Makanae; Koichi Nakazato; Ishii Naokata
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

View more
  1 in total

1.  TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression.

Authors:  Yuhao Yuan; Qing Liu; Ziyi Wu; Wei Zhong; Zili Lin; Wei Luo
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.